Articles

heart valve repair hybrid or cath lab

Boston Scientific Corp. has received CE mark for its Lotus Valve System, a transcatheter aortic valve replacement (TAVR) technology. This key approval offers an effective new...

The CoreValve U.S. pivotal trial showed very positive results for the Medtronic CoreValve system, comparable or better than data from the Sapien Partner Trial.

MitraClip, Abbott, transcatheter mitral valve repair, FDA approval

The U.S. Food and Drug Administration (FDA) has granted market clearance for the MitraClip, the first minimally invasive transcatheter device to repair mitral regurgitation (MR). The device is...

Edwards Sapien TAVR valve

As a cutting-edge technique, many hospitals around the country are investigating the development of their own TAVR programs. Starting a TAVR program requires a collaborative commitment to care and...

Direct Flow Medical Inc. announced the first patient enrollment in the U.S. SALUS clinical trial. The trial will study the Direct Flow Medical Transcatheter Aortic Heart Valve System,...

July 12, 2013 — A Chicago native living in southern California was the first patient at Scripps Health to receive a MitraClip as part of the clinical outcomes assessment of the MitraClip...

Researchers have announced the results of a clinical study that shows a key difference in the patient’s baseline heart size and function following transcatheter valve replacement (TAVR) that may...

Abbott has announced publication of positive outcomes from two European post-approval studies of the catheter-based MitraClip therapy for the treatment of mitral regurgitation (MR). Results...

Direct Flow Medical Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the SALUS feasibility...

June 3, 2013 — Medtronic Inc. announced it has received CE mark for valve-in-valve (VIV) procedures using the CoreValve and CoreValve Evolut transcatheter aortic valve implantation (TAVI) systems...